Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Detection of acetylsalicylic acid and omega-3 fatty acids in tear fluid using Schirmer test strips and mass spectrometry
2020-004978-22Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Nov 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of aspirin and omega-3 fatty acid in dry eye syndrome (DED), sponsored by Medical University of Vienna. Primary endpoint: Concentration of omega-3 fatty acids/acetylsalicylic acid detectable in Schirmer’s tear strips. Started Nov 2020; status: completed.
02
Drugs
aspirinomega-3 fatty acid
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2020-004978-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004978-22.